Pfizer tops estimates, raises profit guidance even as sales fall

1. Pfizer raised full-year profit guidance to $3-$3.15 per share. 2. Third-quarter earnings beat estimates, driven by cost-cutting measures. 3. Revenue decreased 6% due to lower Covid vaccine demand. 4. Company plans to invest $70 billion in U.S. manufacturing. 5. Pfizer is in a bidding war for biotech Metsera against Novo Nordisk.